Table of Contents
Scholarly Research Exchange
Volume 2009, Article ID 938325, 7 pages
http://dx.doi.org/10.3814/2009/938325
Review Article

Vasoactive Intestinal Peptide Tumor

1Departments of Dermatology and Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA
2Department of Internal Medicine, University of Southern California, Los Angeles, CA 90033, USA

Received 13 October 2008; Accepted 18 February 2009

Copyright © 2009 Naveed Natanzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. V. Verner and A. B. Morrison, “Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia,” The American Journal of Medicine, vol. 25, no. 3, pp. 374–380, 1958. View at Publisher · View at Google Scholar
  2. G. J. Krejs, “VIPoma syndrome,” The American Journal of Medicine, vol. 82, no. 5, pp. 37–48, 1987. View at Google Scholar
  3. D. Schoevaerdts, L. Favet, D. Zekry, C. C. Sieber, and J. P. Michel, “Vipoma: effective treatment with octreotide in the oldest old,” Journal of the American Geriatrics Society, vol. 49, no. 4, pp. 496–497, 2001. View at Publisher · View at Google Scholar
  4. I. Drivas, R. Mansberg, and J. M. Roberts, “VIPoma: a rare cause of a pancreatic mass,” Clinical Nuclear Medicine, vol. 29, no. 3, pp. 201–203, 2004. View at Publisher · View at Google Scholar
  5. M. S. Murphy, A. Sibal, and J. R. Mann, “Persistent diarrhoea and occult vipomas in children,” British Medical Journal, vol. 320, no. 7248, pp. 1524–1526, 2000. View at Publisher · View at Google Scholar
  6. J. Keller, J. C. Mueller-Wolf, K. Ahmadi-Simab, C. Fibbe, U. Rosien, and P. Layer, “Do elevated plasma Vasoactive Intestinal Polypeptide (VIP) levels cause small intestinal motor disturbances in humans?,” Digestive Diseases and Sciences, vol. 50, no. 2, pp. 276–282, 2005. View at Publisher · View at Google Scholar
  7. S. Y. Peng, J. T. Li, Y. B. Liu et al., “Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma,” Pancreas, vol. 28, no. 1, pp. 93–97, 2004. View at Publisher · View at Google Scholar
  8. S. H. Quak, K. Prabhakaran, R. Kwok, and A. P. O'Reilly, “Vasoactive intestinal peptide secreting tumours in children: a case report with literature review,” Australian Paediatric Journal, vol. 24, no. 1, pp. 55–58, 1988. View at Google Scholar
  9. M. G. Kane and T. M. O'Dorisio, “VIPoma syndrome,” Seminars in Oncology, vol. 14, no. 3, pp. 282–291, 1983. View at Google Scholar
  10. F. Aspestrand, F. Kolmannskog, and M. Jacobsen, “CT, MR imaging and angiography in pancreatic apudomas,” Acta Radiologica, vol. 34, no. 5, pp. 468–473, 1993. View at Google Scholar
  11. C. Vick, C. J. Zech, S. Höpfner, T. Waggershauser, and M. Reiser, “Imaging of neuroendocrine tumors of the pancreas,” Radiologe, vol. 43, no. 4, pp. 293–300, 2003. View at Publisher · View at Google Scholar · View at PubMed
  12. R. C. Semelka, C. M. Custodio, N. Cem Balci, and J. T. Woosley, “Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI,” Journal of Magnetic Resonance Imaging, vol. 11, no. 2, pp. 141–148, 2000. View at Publisher · View at Google Scholar
  13. M. A. Anderson, S. Carpenter, N. W. Thompson, T. T. Nostrant, G. H. Elta, and J. M. Scheiman, “Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas,” American Journal of Gastroenterology, vol. 95, no. 9, pp. 2271–2277, 2000. View at Publisher · View at Google Scholar
  14. J. C. Ardengh, G. A. de Paulo, and A. P. Ferrari, “EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery,” Gastrointestinal Endoscopy, vol. 60, no. 3, pp. 378–384, 2004. View at Publisher · View at Google Scholar
  15. H. J. C. Shin, S. Lahoti, and N. Sneige, “Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M. D. Anderson cancer center experience,” Cancer, vol. 96, no. 3, pp. 174–180, 2002. View at Publisher · View at Google Scholar · View at PubMed
  16. National Cancer Institute, “Pancreatic tumors: miscellaneous islet cell carcinoma,” July 2006, http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page8.
  17. C. G. Moertel, C. M. Johnson, M. A. McKusick et al., “The management of patients with advanced carcinoid tumors and islet cell carcinomas,” Annals of Internal Medicine, vol. 120, no. 4, pp. 302–309, 1994. View at Google Scholar
  18. N. L. Kelekis and R. C. Semelka, “MRI of pancreatic tumors,” European Radiology, vol. 7, no. 6, pp. 875–886, 1997. View at Publisher · View at Google Scholar
  19. I. Virgolini, T. Traub-Weidinger, and C. Decristoforo, “Nuclear medicine in the detection and management of pancreatic islet-cell tumours,” Clinical Endocrinology & Metabolism, vol. 19, no. 2, pp. 213–227, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. I. Virgolini, A. Kurtaran, M. Leimer et al., “Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy,” Journal of Nuclear Medicine, vol. 39, no. 9, pp. 1575–1579, 1998. View at Google Scholar
  21. N. Scheffold, R. Arnold, and J. Cyran, “Metastasizing VIPoma of the pancreas: diagnostic aspects and treatment with octreotide (somatostatin analogue),” Deutsche Medizinische Wochenschrift, vol. 120, no. 43, pp. 1463–1467, 1995 (German). View at Publisher · View at Google Scholar
  22. S. Riestra, A. Suárez, L. Rodrigo et al., “Vipoma of the pancreas. Apropos of a case and review of the literature,” Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva, vol. 77, no. 5, pp. 377–383, 1990. View at Google Scholar
  23. R. Ram, N. Natanzi, P. Saadat, D. Eliav, and M. S. Vadmal, “Skin metastasis of pancreatic vasoactive intestinal polypeptide tumor: case report and review of the literature,” Archives of Dermatology, vol. 142, no. 7, pp. 946–947, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. S. J. Moug, E. Leen, P. G. Horgan, and C. W. Imrie, “Radiofrequency ablation has a valuable therapeutic role in metastatic VIPoma,” Pancreatology, vol. 6, no. 1-2, pp. 155–159, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. C. G. Moertel, M. Lefkopoulo, S. Lipsitz, R. G. Hahn, and D. Klaassen, “Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma,” The New England Journal of Medicine, vol. 326, no. 8, pp. 519–523, 1992. View at Google Scholar
  26. C. Cellier, C. Yaghi, E. Cuillerier et al., “Metastatic jejunal VIPoma: beneficial effect of combination therapy with interferon-α and 5-fluorouracil,” American Journal of Gastroenterology, vol. 95, no. 1, pp. 289–293, 2000. View at Publisher · View at Google Scholar
  27. B. Eriksson and K. Oberg, “An update of the medical treatment of malignant endocrine pancreatic tumors,” Acta Oncologica, vol. 32, no. 2, pp. 203–208, 1993. View at Publisher · View at Google Scholar
  28. C. C. Case, K. Wirfel, and R. Vassilopoulou-Sellin, “Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report,” Medical Oncology, vol. 19, no. 3, pp. 181–187, 2002. View at Publisher · View at Google Scholar · View at PubMed
  29. S. Ito, M. Kasturagi, H. Otsuji et al., “Transcatheter embolization of metastatic liver VIPoma: report of a case,” Japanese Journal of Clinical Radiology, vol. 32, no. 10, pp. 1169–1172, 1987. View at Google Scholar
  30. M. T. Tauber, A. G. Harris, and P. Rochiccioli, “Clinical use of the long acting somatostatin analogue octreotide in pediatrics,” European Journal of Pediatrics, vol. 153, no. 5, pp. 304–310, 1994. View at Publisher · View at Google Scholar
  31. K. D. Buchanan, “Effects of sandostatin on neuroendocrine tumours of the gastrointestinal system,” Recent Results in Cancer Research, vol. 129, pp. 45–55, 1993. View at Google Scholar
  32. S. R. Bloom, “Vipoma, glucagonoma and the role of Sandostatin,” NATNews, vol. 26, no. 7, p. 15, 1989. View at Google Scholar
  33. A. W. Kirkpatrick, S. S. Hanna, and B. A. J. Skinner, “Surgical treatment of pancreatic cholera: a case report,” Canadian Journal of Surgery, vol. 39, no. 2, pp. 155–158, 1996. View at Google Scholar
  34. B. Brichard, R. Fiasse, J. P. Buts et al., “Vipoma in an adolescent: treatment with a delayed-action somatostatin analog, octreotide or SMS 201-995, and surgical removal,” Acta Gastroenterologica Belgica, vol. 53, no. 2, pp. 188–197, 1990. View at Google Scholar